CONQUEST

Platform Clinical Study for Conquering Scleroderma

AmlitelimabOngoingRecruitingPhase 2Open NCT06195072 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…